Ms Hyveled joined Novo Nordisk in 1992 and has worked in a variation of leadership positions across the drug development disciplines. She is currently working as Vice President in Business Assurance in a senior facilitator’s role. Ms Hyveled holds a Master of Science from Copenhagen University, Denmark, from 1992 and a sectorial MBA (Master of Medical Business Strategies) from Copenhagen Business School, Denmark, from 2011. Liselotte Hyveled has been an employee-elected member of the Board of Directors since March 2014. Her term as a board member expires in March 2018. Ms Hyveled became a member of the Research & Development Committee at Novo Nordisk A/S in March 2017. Ms Hyveled is a female Danish national, born January 1966. Ms Hyveled joined Novo Nordisk in 1992 and has worked in a variation of leadership positions across the drug development disciplines. She is currently working as Vice President in Business Assurance in a senior facilitator’s role. Ms Hyveled holds a Master of Science from Copenhagen University, Denmark, from 1992 and a sectorial MBA (Master of Medical Business Strategies) from Copenhagen Business School, Denmark, from 2011. Liselotte Hyveled has been an employee-elected member of the Board of Directors since March 2014. Her term as a board member expires in March 2018. Ms Hyveled became a member of the Research & Development Committee at Novo Nordisk A/S in March 2017. Ms Hyveled is a female Danish national, born January 1966.

Pathology